ATE207122T1 - Polyvalenter repressor von gen-funktionen - Google Patents

Polyvalenter repressor von gen-funktionen

Info

Publication number
ATE207122T1
ATE207122T1 AT90109892T AT90109892T ATE207122T1 AT E207122 T1 ATE207122 T1 AT E207122T1 AT 90109892 T AT90109892 T AT 90109892T AT 90109892 T AT90109892 T AT 90109892T AT E207122 T1 ATE207122 T1 AT E207122T1
Authority
AT
Austria
Prior art keywords
viral
htlv
hiv
rev
transdominant
Prior art date
Application number
AT90109892T
Other languages
English (en)
Inventor
Helmut Bachmayer
Ernst Boehnlein
Bryan R Cullen
Warner C Greene
Joachim Hauber
Original Assignee
Novartis Ag
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898915602A external-priority patent/GB8915602D0/en
Priority claimed from GB898924396A external-priority patent/GB8924396D0/en
Application filed by Novartis Ag, Univ Duke filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE207122T1 publication Critical patent/ATE207122T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT90109892T 1989-05-25 1990-05-23 Polyvalenter repressor von gen-funktionen ATE207122T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35687889A 1989-05-25 1989-05-25
GB898915602A GB8915602D0 (en) 1989-07-07 1989-07-07 Multivalent repressor of gene function
GB898924396A GB8924396D0 (en) 1989-10-30 1989-10-30 Multivalent repressor of gene function
US44267089A 1989-11-29 1989-11-29

Publications (1)

Publication Number Publication Date
ATE207122T1 true ATE207122T1 (de) 2001-11-15

Family

ID=27450368

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90109892T ATE207122T1 (de) 1989-05-25 1990-05-23 Polyvalenter repressor von gen-funktionen

Country Status (13)

Country Link
EP (1) EP0406557B1 (de)
JP (2) JP3126378B2 (de)
KR (1) KR100215949B1 (de)
AT (1) ATE207122T1 (de)
AU (2) AU648256B2 (de)
CA (1) CA2032158C (de)
DE (1) DE69033829T2 (de)
DK (1) DK0406557T3 (de)
ES (1) ES2166748T3 (de)
FI (1) FI110437B (de)
HU (2) HU217091B (de)
IL (1) IL94482A (de)
WO (1) WO1990014427A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2115622T5 (es) * 1990-10-17 2003-03-16 Us Health Clones moleculares de hiv-1 y usos de los mismos.
US5534408A (en) * 1993-09-24 1996-07-09 University Of Massachusetts Medical Center 2-deoxystreptamine aminoglycoside inhibition of HIV RRE/Rev binding
US5650306A (en) * 1993-06-07 1997-07-22 University Of Michigan Recombinant nucleic acids for inhibiting HIV gene expression
AU7263994A (en) * 1993-08-06 1995-02-28 Kai Juhani Ernst Krohn Novel mutated human and simian immunodeficiency viruses and vaccines containing said viruses
US5981258A (en) * 1993-12-13 1999-11-09 Transgene S.A. Composition of trans-dominant variants of viral proteins for obtaining an antiviral effect
FR2713651B1 (fr) * 1993-12-13 1996-04-19 Transgene Sa Nouvelle composition pour un effet antiviral.
US6228369B1 (en) 1993-12-13 2001-05-08 Transgene S.A. Composition of trans-dominant variants of viral proteins for obtaining an anti-viral effect
SK283878B6 (sk) 1996-01-26 2004-04-06 Virco B.V.B.A. In vitro spôsob určenia HIV chemoterapie HIV pozitívnych pacientov
IL127038A0 (en) * 1996-06-06 1999-09-22 Novartis Ag Inhibition of hiv-1 replication by antisense rna expression
US6776986B1 (en) 1996-06-06 2004-08-17 Novartis Ag Inhibition of HIV-1 replication by antisense RNA expression
US6194212B1 (en) 1996-06-06 2001-02-27 Novartis Ag Vectors comprising SAR elements
IL143278A0 (en) * 1998-12-22 2002-04-21 Subsidiary No 3 Inc Genetic supressor elements against human immunodeficiency virus
AU2493300A (en) * 1999-01-06 2000-07-24 Regents Of The University Of California, The Modulation of hiv replication using sam68
US7300790B2 (en) 2003-01-23 2007-11-27 Iogenetics, Llc Transgenic animals expressing transdominant negative retroviral nucleic acids and proteins
JP5653549B1 (ja) 2014-05-30 2015-01-14 株式会社松風 イオン徐放性歯科用レジン系仮封材組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935372A (en) * 1986-05-20 1990-06-19 Dana Farber Cancer Institute Art nucleotide segments, vectors, cell lines methods of preparation and use

Also Published As

Publication number Publication date
FI910371A0 (fi) 1991-01-24
WO1990014427A2 (en) 1990-11-29
FI110437B (fi) 2003-01-31
HUT56135A (en) 1991-07-29
WO1990014427A3 (en) 1991-01-10
EP0406557A3 (en) 1991-05-02
DK0406557T3 (da) 2002-02-11
DE69033829T2 (de) 2002-04-04
JP3159671B2 (ja) 2001-04-23
HU217091B (hu) 1999-11-29
DE69033829D1 (de) 2001-11-22
HU211530A9 (en) 1995-11-28
IL94482A0 (en) 1991-03-10
ES2166748T3 (es) 2002-05-01
JPH10165188A (ja) 1998-06-23
EP0406557B1 (de) 2001-10-17
CA2032158C (en) 2009-09-15
KR100215949B1 (ko) 1999-08-16
AU6757394A (en) 1994-11-17
IL94482A (en) 2003-09-17
JP3126378B2 (ja) 2001-01-22
AU648256B2 (en) 1994-04-21
CA2032158A1 (en) 1990-11-26
AU678478B2 (en) 1997-05-29
HU904245D0 (en) 1991-06-28
JPH04500009A (ja) 1992-01-09
KR920701440A (ko) 1992-08-11
AU5738890A (en) 1990-12-18
EP0406557A2 (de) 1991-01-09

Similar Documents

Publication Publication Date Title
DE69033829D1 (de) Polyvalenter Repressor von Gen-Funktionen
ES2123065T3 (es) Hidroxietilamino-sulfonamidas utiles como inhibidores de proteasas retroviricas.
RU95106823A (ru) Сукциноиламиногидроксиэтиламиносульфонамиды, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции способ лечения спида
DE69301017D1 (de) Von perhalogenierten sultonen abgeleiteten monomere,sowie aus diesen monomeren hergestellte polymere
CA2051562A1 (en) Bacillus thuringiensis isolates active against dipteran pests
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
ATE122385T1 (de) Azeotrope oder azeotropähnliche zusammensetzung auf der basis von wasserstoff enthaltenden chlorfluorkohlenwasserstoffen.
FI853648A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva 4,5-dihydro-4-okso-2-/(2-trans-fenylcyklopropyl) amino/-3-furankarboxylsyror och derivat daerav.
DE69524971D1 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
EP0739901A3 (de) Oligoribonukleotid-Derivate und Verwendung davon als Antiviral Arzneimittel
AU2253288A (en) Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
EP0474797A4 (en) Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof
GR1000639B (el) Μεθοδος για την παρασκευη μιας συνθεσεως για την αντιμετωπιση της αμυγδαλιτιδας.
NL7510560A (nl) 4-stilbenyl-1,2,3-triazolen, werkwijze om ze te bereiden, alsmede hun toepassing als optische bleekmiddelen.
SU872166A1 (ru) Способ восстановлени изношенной поверхности изделий
Michailova Polytene chromosomes of different subfamilies of family Chironomidae, Diptera
TR23745A (tr) 1-dimetilkarbomoil-3-suebstituee 1h-1.2.4-triazoller
DE69434019D1 (de) Zusammensetzung von transdominanten varianten von virus- proteinen zur antiviralen wirkung
FR2632310B1 (fr) Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
SU834585A1 (ru) Цифровой анализатор
MD89C2 (ro) Procedeu de obţinere a derivaţilor izoxazolului
FR2305440A1 (fr) Nouveaux phosphonates d'o,o-dialkyle, leur preparation et leur utilisation comme insecticides
DK99588A (da) 2-(aminoalkythio)methyl-1,4-dihydropyridin-forbindelser, en fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
ATE93840T1 (de) Diarylalkanoide mit wirkung als lipoxygenaseinhibitoren.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time